Quanterix is a life sciences company that develops ultra-sensitive biomarker detection and spatial biology analysis platforms for research, diagnostics, and clinical laboratory applications. The company manufactures and sells automated instruments (Simoa platforms for digital immunoassay and PhenoCycler/PhenoImager systems for tissue imaging) and accompanying assay kits targeting neurology, oncology, immunology, and infectious disease; it serves research laboratories, academic institutions, contract research organizations, and biopharmaceutical companies globally, with over 2,500 instruments installed across these markets. Revenue is generated through direct instrument sales, consumables (assay kits and reagents), contract research and clinical laboratory services, extended warranties, and intellectual property sublicensing; the company has also launched clinical diagnostic testing through its CLIA-certified laboratory, offering Alzheimer's disease blood tests to healthcare providers, and pursues a growth strategy centered on expanding its assay menu, entering adjacent markets, and translating research tools into clinical diagnostics.